OTCMKTS:GNWSD StageZero Life Sciences (GNWSD) Stock Price, News & Analysis → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Free GNWSD Stock Alerts $0.04 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$0.04▼$0.0450-Day Range$0.03▼$0.0452-Week Range$0.17▼$0.89Volume20,500 shsAverage Volume4,987 shsMarket Capitalization$1.72 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get StageZero Life Sciences alerts: Email Address Ad Behind the MarketsCentral Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>> About StageZero Life Sciences Stock (OTCMKTS:GNWSD)StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall in 1998 and is headquartered in Markham, Canada.Read More GNWSD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GNWSD Stock News HeadlinesMarch 11, 2024 | bizjournals.comLA, Orange County life-science vacancy rate hits 3%February 27, 2024 | msn.com‘An extremely aggressive timeline’: Rhode Island Life Sciences Hub to hire inaugural CEO by MayMarch 29, 2024 | Behind the Markets (Ad)Central Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.February 23, 2024 | bizjournals.comCommentary: Why Boston’s life sciences sector should fuel a new climatetech nicheFebruary 15, 2024 | yahoo.comLife Below Zero: Next Generation Season 2 Streaming: Watch & Stream Online via Disney PlusNovember 14, 2023 | finanznachrichten.deStageZero Life Sciences Ltd: StageZero Life Sciences Partners with My One Medical Source and 1,000+ Medical Access Points in the USANovember 14, 2023 | finance.yahoo.comStageZero Life Sciences Partners with My One Medical Source and 1,000+ Medical Access Points in the USANovember 10, 2023 | news.yahoo.comReport: Utah’s life sciences industries are an economic juggernaut on the riseMarch 29, 2024 | Behind the Markets (Ad)Central Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.November 8, 2023 | benzinga.comUtah Ranks Among Fastest Growing Life Sciences Industries in the NationNovember 7, 2023 | finance.yahoo.comStageZero Life Sciences' Clinical Business Introduces Fourth Pillar to Cancer OfferingsOctober 26, 2023 | theglobeandmail.comClosing Bell: Stagezero Life Sciences Ltd flat on Thursday (SZLS)October 23, 2023 | msn.comGen Z Is Heading South For More Affordable HomesOctober 21, 2023 | theglobeandmail.comClosing Bell: Stagezero Life Sciences Ltd down on Friday (SZLS)October 20, 2023 | finanznachrichten.deStageZero Life Sciences Ltd: StageZero Life Sciences' Clinical Business Introduces Third Pillar to Cancer OfferingsOctober 20, 2023 | finance.yahoo.comStageZero Life Sciences’ Clinical Business Introduces Third Pillar to Cancer OfferingsOctober 18, 2023 | theglobeandmail.comClosing Bell: Stagezero Life Sciences Ltd flat on Wednesday (SZLS)October 11, 2023 | theglobeandmail.comClosing Bell: Stagezero Life Sciences Ltd up on Wednesday (SZLS)October 7, 2023 | theglobeandmail.comClosing Bell: Stagezero Life Sciences Ltd flat on Friday (SZLS)September 6, 2023 | msn.comGeneone Life Science to raise 2.5 bln won via stock offeringJune 1, 2023 | bizjournals.comHere's how much Boston's life sciences industry has grown since 2018May 31, 2023 | msn.comMass. saw a 14.6 percent increase in life sciences jobs during pandemicMay 16, 2023 | finance.yahoo.comStageZero Life Sciences, Ltd Announces Q1 2023 Financial Results - 15.2% Growth in Revenue over Q4 2022 - and Operational UpdateMay 5, 2023 | msn.comGenemod lands $4.5M for life sciences data storage and collaboration platformMarch 18, 2023 | msn.comThe New Era of Life SciencesFebruary 2, 2023 | benzinga.comStageZero Life Sciences Announces Change of Date of Special Meeting of Shareholders; Will Combine with AGM in Q2 2023November 21, 2022 | ca.finance.yahoo.comStocks in play: StageZero Life Sciences Ltd.See More Headlines Receive GNWSD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:GNWSD CUSIPN/A CIKN/A Webwww.stagezerolifesciences.com Phone(855) 420-7140FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,480,000.00 Net Margins217.39% Pretax MarginN/A Return on EquityN/A Return on Assets-61.21% Debt Debt-to-Equity RatioN/A Current Ratio0.09 Quick Ratio0.06 Sales & Book Value Annual Sales$140,000.00 Price / Sales12.25 Cash FlowN/A Price / Cash FlowN/A Book Value($0.13) per share Price / Book-0.27Miscellaneous Outstanding Shares48,940,000Free FloatN/AMarket Cap$1.72 million OptionableNot Optionable Beta2.97 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesJames R. Howard-TrippExecutive Chairman & Chief Executive OfficerRebecca GrecoHead-Investor RelationsKey CompetitorsSunshine BiopharmaNASDAQ:SBFMDigipathOTCMKTS:DIGPAoxing PharmaceuticalOTCMKTS:AOXG60 Degrees PharmaceuticalsNASDAQ:SXTPEscalon MedicalOTCMKTS:ESMCView All Competitors GNWSD Stock Analysis - Frequently Asked Questions How have GNWSD shares performed in 2024? StageZero Life Sciences' stock was trading at $0.0294 at the beginning of the year. Since then, GNWSD stock has increased by 19.2% and is now trading at $0.0351. View the best growth stocks for 2024 here. How do I buy shares of StageZero Life Sciences? Shares of GNWSD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:GNWSD) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding StageZero Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.